This post from the Pharmalot blog details companies that have done the most to make drugs available to developing companies. Not surprisingly (to me anyway), European companies led their US counterparts. The number one company was GSK.
Again, I wasn't too surprised by this. I figured perhaps something must have rubbed off from the Wellcome acquisition - as that company certainly represented a more charitable disposition historically.
It is good to see that someone is creating this type of Access to Medicine Index (2nd since 2008). If you saw my post on Betterness is Good Business - and more importantly Umair Hague's HBR article on this topic - you would learn that a better social conscience and stewardship has historically resulted in better ROIs for Companies practicing that philosophy.
That may speak to investment opportunities with GSK, Merck, Novartis and others at the top of the list. The index exists by the way to allow investor's to assess these pharma companies on their social responsibility score.
Posted by Bruce Lehr June 22nd 2010.